Candel Therapeutics (CADL)
NASDAQ:CADL
US Market
Holding CADL?
Track your performance easily

Candel Therapeutics (CADL) Financial Statements

184 Followers

Candel Therapeutics Financial Overview

Candel Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.7; its P/E ratio is -4.43; Candel Therapeutics is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -21.67M$ -7.58M$ -7.77M$ -8.97M$ -8.90M
EBITDA$ -21.42M$ -7.32M$ -7.52M-$ -9.10M
Net Income Common Stockholders$ -22.24M$ -8.22M$ -8.44M$ -9.61M$ -8.79M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 21.45M$ 25.71M$ 42.98M$ 51.89M$ 59.26M
Total Assets$ 26.48M$ 31.22M$ 50.06M$ 58.71M$ 67.24M
Total Debt$ 18.56M$ 21.09M$ 22.77M$ 22.78M$ 22.79M
Net Debt$ -2.89M$ -4.63M$ -20.21M$ -29.11M$ -36.47M
Total Liabilities$ 36.46M$ 25.24M$ 27.04M$ 27.94M$ 27.59M
Stockholders Equity$ -9.97M$ 5.98M$ 23.02M$ 30.77M$ 39.65M
Cash Flow-
Free Cash Flow$ -6.20M$ -8.45M$ -8.91M-$ -10.80M
Operating Cash Flow$ -6.20M$ -8.44M$ -8.81M-$ -10.82M
Investing Cash Flow$ -6.00K$ -7.00K$ -103.00K-$ 19.00K
Financing Cash Flow$ 1.95M$ -1.25M---
Currency in USD

Candel Therapeutics Earnings and Revenue History

Candel Therapeutics Debt to Assets

Candel Therapeutics Cash Flow

Candel Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis